{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T03:54:35Z","timestamp":1783223675723,"version":"3.54.6"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TI 323\/4-1"],"award-info":[{"award-number":["TI 323\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background and aims<\/jats:title><jats:p>There is growing interest in T cell-based immune therapies for a functional cure of chronic HBV infection including check-point inhibition, T cell-targeted vaccines or TCR-grafted effector cells. All these approaches depend on recognition of HLA class I-presented viral peptides. The HBV core region 18-27 is an immunodominant target of CD8+ T cells and represents the prime target for T cell-based therapies. Here, a high-resolution analysis of the core<jats:sub>18-27<\/jats:sub> specific CD8+ T cell and the selected escape pathways was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>HLA class I typing and viral sequence analyses were performed for 464 patients with chronic HBV infection. HBV-specific CD8+ T-cell responses against the prototype and epitope variants were characterized by flow cytometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Consistent with promiscuous presentation of the core<jats:sub>18-27<\/jats:sub> epitope, antigen-specific T cells were detected in patients carrying HLA-A*02:01, HLA-B*35:01, HLA-B*35:03 or HLA-B*51:01. Sequence analysis confirmed reproducible selection pressure on the core<jats:sub>18-27<\/jats:sub> epitope in the context of these alleles. Interestingly, the selected immune escape pathways depend on the presenting HLA-class I-molecule. Although cross-reactive T cells were observed, some epitope variants achieved functional escape by impaired TCR-interaction or disturbed antigen processing. Of note, selection of epitope variants was exclusively observed in HBeAg negative HBV infection and here, detection of variants associated with significantly greater magnitude of the CD8 T cell response compared to absence of variants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The core<jats:sub>18-27<\/jats:sub> epitope is highly variable and under heavy selection pressure in the context of different HLA class I-molecules. Some epitope variants showed evidence for impaired antigen processing and reduced presentation. Viruses carrying such escape substitutions will be less susceptible to CD8+ T cell responses and should be considered for T cell-based therapy strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1045498","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T12:36:20Z","timestamp":1668083780000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles"],"prefix":"10.3389","volume":"13","author":[{"given":"Andreas","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Brinkmann-Paulukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wisskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Menne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe Salimi","family":"Alizei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helenie","family":"Kefalakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Theissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Schulze zur Wiesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala K.","family":"Maini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke RM","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko M.","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Neumann-Haefelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01032-19","article-title":"Revisiting hepatitis b virus: Challenges of curative therapies","volume":"93","author":"Hu","year":"2019","journal-title":"J Virol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis b","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0196-9","article-title":"Restoring, releasing or replacing adaptive immunity in chronic hepatitis b","volume":"16","author":"Maini","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting innate and adaptive immune responses to cure chronic HBV infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis b virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J virology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S2468-1253(18)30007-4","article-title":"Defective T-cell immunity in hepatitis b virus infection: why therapeutic vaccination needs a helping hand","volume":"3","author":"Maini","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5009\/gnl17233","article-title":"Immunotherapy for chronic hepatitis b virus infection","volume":"12","author":"Bertoletti","year":"2018","journal-title":"Gut Liver"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.3.933","article-title":"Cytotoxic T lymphocyte response to a wild type hepatitis b virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope","volume":"180","author":"Bertoletti","year":"1994","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27771","article-title":"Adaptation of the hepatitis b virus core protein to CD8 T-cell selection pressure","volume":"62","author":"Kefalakes","year":"2015","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/369407a0","article-title":"Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells","volume":"369","author":"Bertoletti","year":"1994","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119559","article-title":"Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis","volume":"100","author":"Bertoni","year":"1997","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.8.3984-3987.2001","article-title":"Degenerate immunogenicity of an HLA-A2-restricted hepatitis b virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51","volume":"75","author":"Thimme","year":"2001","journal-title":"J virology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01505-07","article-title":"Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis b virus infections","volume":"82","author":"Depla","year":"2008","journal-title":"J virology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01124-08","article-title":"Host ethnicity and virus genotype shape the hepatitis b virus-specific T-cell repertoire","volume":"82","author":"Tan","year":"2008","journal-title":"J virology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex vivo analysis of hepatitis b virus-specific CD8(+) T cells associated with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120228","article-title":"T Cell receptor grafting allows virological control of hepatitis b virus infection","volume":"129","author":"Wisskirchen","year":"2019","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118191","article-title":"Hepatitis b virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection","volume":"96","author":"Rehermann","year":"1995","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260435","article-title":"Molecular features of the hepatitis b virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor","volume":"26","author":"Bertoletti","year":"1997","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2006.758_5.x","article-title":"Typing of potential and selected donors for transplant: methodology and resolution","author":"Oudshoorn","year":"2007","journal-title":"Tissue Antigens"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.01.030","article-title":"Decades after recovery from hepatitis b and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable","volume":"63","author":"Kefalakes","year":"2015","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102235","article-title":"Hepatitis c virus hypervariable region 1 variants presented on hepatitis b virus capsid-like particles induce cross-neutralizing antibodies","volume":"9","author":"Lange","year":"2014","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.10.025","article-title":"Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines","volume":"55","author":"Gehring","year":"2011","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182936","article-title":"Isolation and functional characterization of hepatitis b virus-specific T-cell receptors as new tools for experimental and clinical use","volume":"12","author":"Wisskirchen","year":"2017","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","article-title":"Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection","volume":"68","author":"Hoogeveen","year":"2019","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.8.4870-4876.2005","article-title":"Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis c virus infection","volume":"79","author":"Kimura","year":"2005","journal-title":"J virology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420985","article-title":"Hepatitis c virus mutation affects proteasomal epitope processing","volume":"114","author":"Seifert","year":"2004","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1128\/JVI.01993-15","article-title":"Distinct escape pathway by hepatitis c virus genotype 1a from a dominant CD8+ T cell response by selection of altered epitope processing","volume":"90","author":"Walker","year":"2015","journal-title":"J virology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02521","article-title":"Immunomodulatory function of HBeAg related to short-sighted evolution, transmissibility, and clinical manifestation of hepatitis b virus","volume":"9","author":"Kramvis","year":"2018","journal-title":"Front Microbiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0406282101","article-title":"A function of the hepatitis b virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00430-014-0372-z","article-title":"Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections","volume":"204","author":"Timm","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041006","article-title":"CD8 epitope escape and reversion in acute HCV infection","volume":"200","author":"Timm","year":"2004","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2014.12.008","article-title":"HIV-1 adaptation to HLA: a window into virus-host immune interactions","volume":"23","author":"Carlson","year":"2015","journal-title":"Trends Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06728-11","article-title":"Widespread impact of HLA restriction on immune control and escape pathways of HIV-1","volume":"86","author":"Carlson","year":"2012","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02572-12","article-title":"Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity","volume":"87","author":"Yagita","year":"2013","journal-title":"J virology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34961","article-title":"Variations in HLA-b cell surface expression, half-life and extracellular antigen receptivity","volume":"7","author":"Yarzabek","year":"2018","journal-title":"Elife"},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jvh.13011","article-title":"Differential escape of HCV from CD8(+) T cell selection pressure between China and Germany depends on the presenting HLA class I molecule","volume":"26","author":"Xia","year":"2019","journal-title":"J Viral Hepat"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00665","article-title":"Role of HLA adaptation in HIV evolution","volume":"6","author":"Kloverpris","year":"2015","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01590-14","article-title":"Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis c virus on priming and cross-reactivity of CD8+ T cells","volume":"88","author":"Ziegler","year":"2014","journal-title":"J virology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis b virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"PloS Pathog"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.06.093","article-title":"Cell and animal models for studying hepatitis b virus infection and drug development","volume":"156","author":"Hu","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1045498\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T12:36:26Z","timestamp":1668083786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1045498\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2022.1045498"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1045498","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"1045498"}}